Does Wegovy Raise Your Heart Rate? The Side Effect Explained

The common myth: Wegovy 'damages' your heart rhythm

Online forums are full of posts from people who felt their heart thumping after their first Wegovy injection and concluded something had gone wrong. That anxiety is understandable. But the evidence from the large STEP clinical trials, which led to Wegovy's UK licence, tells a more measured story.

Semaglutide does influence heart rate through GLP-1 receptor activity, the same mechanism that reduces appetite also has a mild stimulating effect on the sinoatrial node, the heart's natural pacemaker. The result, on average, is a rise of roughly one to three beats per minute in resting pulse. The full picture of how Wegovy works involves far broader effects on metabolism, but for heart rate specifically, the signal is modest. Most participants in the STEP 1 trial, published in the New England Journal of Medicine, wouldn't have known their resting pulse had changed at all without a monitor to tell them.

What the trials did not show is Wegovy causing arrhythmias, structural heart damage, or clinically dangerous tachycardia in people without a pre-existing cardiac condition. The myth conflates a small, measurable physiological shift with serious harm. They are not the same thing.

What heart-rate changes actually feel like on Wegovy

Palpitations (a fluttering or racing sensation in the chest) are listed in Wegovy's patient information leaflet as a recognised side effect. They tend to cluster in the first few days after starting treatment or stepping up a dose, when semaglutide levels in the body are rising toward a new steady state.

For most people the sensation passes within a day or two. It can feel alarming if you're not expecting it, which is exactly why discussing it before you start matters. Wegovy's broader side-effect profile is dominated by gastrointestinal effects like nausea and constipation, and palpitations are reported far less frequently than those.

A practical checking habit worth building: take your resting pulse first thing in the morning before you get up, at the same point each week. A free pulse-ox or smartwatch reading takes under a minute and gives you a useful baseline. If you notice a consistent upward drift rather than a brief spike, that's the kind of information worth sharing with your prescriber at your next review.

It's also worth knowing that some symptoms people label as heart-related during Wegovy treatment are actually dehydration from reduced food and fluid intake, or anxiety about starting a new medicine. Neither of those is a heart problem, though both deserve attention. Some people find that digestive discomfort compounds these sensations, and Wegovy heartburn is one specific complaint that can sometimes be mistaken for a cardiac symptom. Some people experience very few side effects at all, and heart rate changes fall into that category for most.

When a change in heart rate is a reason to get medical help

The NHS guidance on semaglutide is clear: mild, transient palpitations are not an emergency. What warrants prompt assessment is something different in character, a heartbeat that is very rapid (persistently above around 100 beats per minute at rest), irregular, or accompanied by chest pain, breathlessness, dizziness, or near-fainting.

If any of those apply, seek same-day medical advice from 111 or, if symptoms are severe, 999. Do not simply stop your Wegovy pen without speaking to a prescriber first, abrupt discontinuation is rarely the right call and the decision belongs with a clinician.

Separately, the NHS patient page for semaglutide covers all the side effects worth knowing about, including when to seek help. The MHRA Yellow Card scheme lets you report any suspected side effect directly, patient reports genuinely inform post-market safety monitoring, and the scheme exists for exactly this kind of information.

People with a pre-existing heart rhythm disorder, recent cardiac event, or anyone taking medicines that already affect heart rate should tell their prescriber before starting. That conversation happens as part of the clinical assessment, not as an afterthought. Cardiac considerations for Wegovy patients are covered in more detail for anyone who wants a deeper read.

How suitability is assessed at a clinical level

Wegovy is a prescription-only medicine, which means a clinician, not a checkout cart, decides whether it's appropriate for you. At nume, a GPhC-registered Independent Prescriber personally reads through your consultation answers, including your cardiac history and any medicines you're already taking. That review happens the same day.

If there are questions about your heart health, the prescriber will raise them. Treatment isn't approved automatically, and a concern about heart rate is exactly the kind of thing a thorough clinical review is designed to surface. Semaglutide and cardiac side effects is a related topic our prescribers are well-placed to talk through. If you'd like to explore whether Wegovy could be suitable for you, starting with a free consultation is the right first step, our prescribers discuss both suitability and side effects as part of the process, before any prescription is issued.